These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15939234)

  • 1. Cell culture models of the ocular barriers.
    Hornof M; Toropainen E; Urtti A
    Eur J Pharm Biopharm; 2005 Jul; 60(2):207-25. PubMed ID: 15939234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration.
    Atluri H; Anand BS; Patel J; Mitra AK
    Exp Eye Res; 2004 Apr; 78(4):815-22. PubMed ID: 15037116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RMP-7, a bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig.
    Elliott PJ; Mackic JB; Graney WF; Bartus RT; Zlokovic BV
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2542-7. PubMed ID: 7591644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the posterior segment of the eye.
    Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
    Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits.
    Amar T; Caillaud T; Elena PP
    Curr Eye Res; 2008 Feb; 33(2):149-58. PubMed ID: 18293185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation.
    Hosoya K; Lee VH; Kim KJ
    Eur J Pharm Biopharm; 2005 Jul; 60(2):227-40. PubMed ID: 15939235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium signalling in ocular tissues: functional activity of G-protein and tyrosine-kinase coupled receptors.
    Duncan G; Collison DJ
    Exp Eye Res; 2002 Oct; 75(4):377-89. PubMed ID: 12387785
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
    Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.
    Mannermaa E; Vellonen KS; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1136-63. PubMed ID: 17081648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of ocular drug penetration.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
    Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
    Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
    Okabe K; Kimura H; Okabe J; Ogura Y
    Retina; 2007; 27(6):770-7. PubMed ID: 17621189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues.
    Matsumoto H; Nakamura Y; Iida H; Ito K; Ohguro H
    Exp Eye Res; 2006 Aug; 83(2):348-56. PubMed ID: 16635490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of blood-ocular barrier transporters in retinal drug disposition: an overview.
    Tomi M; Hosoya K
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1111-24. PubMed ID: 20438316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
    Ranta VP; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system.
    Bräuer L; Kindler C; Jäger K; Sel S; Nölle B; Pleyer U; Ochs M; Paulsen FP
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3945-53. PubMed ID: 17724171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery systems for the eye.
    Kearns VR; Williams RL
    Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.